Table 3.
PFDI-20 questionnaire outcomes comparing adolescents, late adolescents, and young women, Brazilian Western Amazon, 2016–2017
| Symptoms
|
Crude model*
|
Adjusted model*
|
||||
|---|---|---|---|---|---|---|
| No
|
Yes
|
PR (95% CI) | P-value | PR (95% CI) | P-value | |
| n (%) | n (%) | |||||
| POPDI score | ||||||
| Young women | 84 (59.6) | 57 (40.4) | Reference | Reference | ||
| Late adolescents | 52 (50.5) | 51 (49.5) | 1.22 (0.93–1.62) | 0.156 | 1.40 (1.05–1.86) | 0.022 |
| Adolescents | 12 (29.3) | 29 (70.7) | 1.75 (1.32–2.32) | <0.001 | 2.02 (1.49–2.75) | <0.001 |
| CRADI score | ||||||
| Young women | 91 (64.5) | 50 (35.5) | Reference | Reference | ||
| Late adolescents | 56 (54.4) | 47 (45.6) | 1.29 (0.95–1.75) | 0.108 | 1.23 (0.89–1.71) | 0.211 |
| Adolescents | 20 (48.8) | 21 (51.2) | 1.44 (0.99–2.10) | 0.054 | 1.42 (0.96–2.10) | 0.076 |
| UDI score | ||||||
| Young women | 91 (64.5) | 50 (35.5) | Reference | Reference | ||
| Late adolescents | 61 (59.2) | 42 (40.8) | 1.15 (0.83–1.59) | 0.396 | 1.25 (0.90–1.76) | 0.186 |
| Adolescents | 15 (36.6) | 26 (63.4) | 1.79 (1.30–2.47) | <0.001 | 2.09 (1.47–2.98) | <0.001 |
| PFDI total score | ||||||
| Young women | 84 (59.6) | 57 (40.4) | Reference | Reference | ||
| Late adolescents | 50 (48.5) | 53 (51.5) | 1.27 (0.97–1.68) | 0.085 | 1.35 (1.01–1.81) | 0.040 |
| Adolescents | 10 (24.4) | 31 (75.6) | 1.87 (1.43–2.44) | <0.001 | 2.12 (1.57–2.87) | <0.001 |
| UI | ||||||
| Young women | 100 (70.9) | 41 (29.1) | Reference | Reference | ||
| Late adolescents | 66 (64.1) | 37 (35.9) | 1.24 (0.86–1.78) | 0.257 | 1.27 (0.86–1.88) | 0.228 |
| Adolescents | 21 (51.2) | 20 (48.8) | 1.68 (1.12–2.52) | 0.013 | 1.75 (1.14–2.69) | 0.010 |
| UUI | ||||||
| Young women | 114 (80.9) | 27 (19.1) | Reference | Reference | ||
| Late adolescents | 83 (80.6) | 20 (19.4) | 1.01 (0.60–1.71) | 0.958 | 1.04 (0.59–1.81) | 0.898 |
| Adolescents | 28 (68.3) | 13 (31.7) | 1.66 (0.94–2.91) | 0.080 | 1.88 (1.02–3.47) | 0.043 |
| SUI | ||||||
| Young women | 114 (80.9) | 27 (19.1) | Reference | Reference | ||
| Late adolescents | 84 (81.6) | 19 (18.4) | 0.96 (0.57–1.64) | 0.890 | 1.09 (0.63–1.91) | 0.750 |
| Adolescents | 28 (68.3) | 13 (31.7) | 1.66 (0.94–2.91) | 0.080 | 2.00 (1.11–3.62) | 0.021 |
| FI | ||||||
| Young women | 135 (95.7) | 6 (4.26) | Reference | Reference | ||
| Late adolescents | 97 (94.2) | 6 (5.8) | 1.37 (0.45–4.13) | 0.577 | 1.46 (0.40–5.27) | 0.567 |
| Adolescents | 33 (80.5) | 8 (19.5) | 4.59 (1.68–12.48) | 0.003 | 4.40 (1.36–14.27) | 0.014 |
| POP | ||||||
| Young women | 135 (95.7) | 6 (4.3) | Reference | Reference | ||
| Late adolescents | 97 (94.2) | 6 (5.8) | 1.37 (0.45–4.13) | 0.577 | 1.52 (0.50–4.63) | 0.457 |
| Adolescents | 39 (95.1) | 2 (4.9) | 1.14 (0.24–5.48) | 0.864 | 1.95 (0.34–11.04) | 0.450 |
Note:
*
Poisson Regression model with robust variance.
Abbreviations: PFDI-20, Pelvic Floor Distress Inventory-20; PR, prevalence ratio; POPDI, Pelvic Organ Prolapse Distress Inventory; CRADI, Colorectal Anal Distress Inventory; UDI, Urinary Distress Inventory; PFDI, Pelvic Floor Distress Inventory; UI, urinary incontinence; UUI, urge urinary incontinence; SUI, stress urinary incontinence; FI, fecal incontinence; POP, pelvic organ prolapse.